Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Follicle Stimulating Hormone (FSH) Receptor in Women With Low Antral Follicle Count

This study has been completed.
Sponsor:
Information provided by:
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT00231504
First received: October 3, 2005
Last updated: January 5, 2010
Last verified: March 2007

October 3, 2005
January 5, 2010
October 2005
March 2009   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00231504 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Study of Follicle Stimulating Hormone (FSH) Receptor in Women With Low Antral Follicle Count
Study of Follicle Stimulating Hormone (FSH) Receptor in Women With Low Antral Follicle Count

The deficit in the total number of antral follicles is associated with a reduction of the ovarian fertility potential in young women.

The principal objective of this study is to evaluate the relationship between FSH receptor polymorphism and antral follicle count.

The investigators have designed a study of FSH receptor polymorphisms P1 and P2 as an association with a low antral follicle count in the ovary.

The present study will compare the prevalence of FSH receptor polymorphisms P1 and P2 in women having reduced follicle count (1 to 9 antral follicles) or normal follicle count (13 to 20 antral follicles) determined by ultrasound scans.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

DNA

Non-Probability Sample

YOUNG WOMAN

  • Antral Follicle Deficit
  • Fertility
Procedure: Blood samples
Blood samples
Other Name: Blood samples
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
82
May 2009
March 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • 18 to 35 years old
  • 1 to 9 or 13 to 20 antral follicles
  • Caucasian, occidental Europe
  • Presence of both ovaries
  • Informed consent

Exclusion Criteria:

  • Ovarian anomalies
  • Menopause
  • Pregnancy
  • Other diseases
Female
18 Years to 35 Years
Yes
Contact information is only displayed when the study is recruiting subjects
France
 
NCT00231504
P041013, CRC04140
Yes
Christophe Aucan, Department Clinical Rechearch of Developpement
Assistance Publique - Hôpitaux de Paris
Not Provided
Principal Investigator: Renato FANCHIN, MD Assistance Publique - Hôpitaux de Paris
Assistance Publique - Hôpitaux de Paris
March 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP